Caissa Capital Management ltd., 10% Owner at Avalo Therapeutics, Inc. (AVTX), bought 2,671 shares at $2.77 ($7K) on 2023-05-25, disclosed to the SEC on 2023-05-30.
Open-market purchase of $7k AVTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.77 | 2,000 | $6K | 74.2% |
| 2 | $2.87 | 671 | $2K | 25.8% |
| Total | $2.80 avg | 2,671 | $7K | 100% |
| Filing → |
| AVTX | BUY | 2023-06-14 | $64K | — | Filing → |
| AVTX | BUY | 2023-06-09 | $56K | — | Filing → |
| AVTX | BUY | 2023-06-02 | $2K | — | Filing → |